Nucleic acid binding, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005730 | nucleolus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: A4HXF9
Term | Name | Level | Count |
---|---|---|---|
GO:0044087 | regulation of cellular component biogenesis | 4 | 1 |
GO:0050789 | regulation of biological process | 2 | 1 |
GO:0050794 | regulation of cellular process | 3 | 1 |
GO:0065007 | biological regulation | 1 | 1 |
GO:0090069 | regulation of ribosome biogenesis | 5 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 10 |
GO:0005488 | binding | 1 | 10 |
GO:0097159 | organic cyclic compound binding | 2 | 10 |
GO:1901363 | heterocyclic compound binding | 2 | 10 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 149 | 153 | PF00656 | 0.704 |
CLV_C14_Caspase3-7 | 155 | 159 | PF00656 | 0.705 |
CLV_C14_Caspase3-7 | 95 | 99 | PF00656 | 0.733 |
CLV_NRD_NRD_1 | 120 | 122 | PF00675 | 0.663 |
CLV_NRD_NRD_1 | 35 | 37 | PF00675 | 0.369 |
CLV_NRD_NRD_1 | 75 | 77 | PF00675 | 0.653 |
CLV_PCSK_KEX2_1 | 136 | 138 | PF00082 | 0.718 |
CLV_PCSK_KEX2_1 | 160 | 162 | PF00082 | 0.720 |
CLV_PCSK_KEX2_1 | 201 | 203 | PF00082 | 0.572 |
CLV_PCSK_KEX2_1 | 35 | 37 | PF00082 | 0.344 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.600 |
CLV_PCSK_PC1ET2_1 | 136 | 138 | PF00082 | 0.718 |
CLV_PCSK_PC1ET2_1 | 160 | 162 | PF00082 | 0.720 |
CLV_PCSK_PC1ET2_1 | 201 | 203 | PF00082 | 0.652 |
CLV_PCSK_PC1ET2_1 | 77 | 79 | PF00082 | 0.600 |
CLV_PCSK_PC7_1 | 132 | 138 | PF00082 | 0.764 |
CLV_PCSK_PC7_1 | 156 | 162 | PF00082 | 0.684 |
CLV_PCSK_SKI1_1 | 176 | 180 | PF00082 | 0.547 |
DEG_SPOP_SBC_1 | 106 | 110 | PF00917 | 0.584 |
DEG_SPOP_SBC_1 | 113 | 117 | PF00917 | 0.608 |
DOC_MAPK_gen_1 | 121 | 129 | PF00069 | 0.553 |
DOC_USP7_MATH_1 | 113 | 117 | PF00917 | 0.778 |
DOC_USP7_MATH_1 | 146 | 150 | PF00917 | 0.732 |
DOC_USP7_UBL2_3 | 122 | 126 | PF12436 | 0.726 |
DOC_USP7_UBL2_3 | 28 | 32 | PF12436 | 0.380 |
DOC_USP7_UBL2_3 | 7 | 11 | PF12436 | 0.444 |
DOC_USP7_UBL2_3 | 73 | 77 | PF12436 | 0.557 |
DOC_WW_Pin1_4 | 138 | 143 | PF00397 | 0.715 |
LIG_14-3-3_CanoR_1 | 140 | 146 | PF00244 | 0.704 |
LIG_14-3-3_CanoR_1 | 172 | 179 | PF00244 | 0.557 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.547 |
LIG_FHA_1 | 57 | 63 | PF00498 | 0.624 |
LIG_FHA_2 | 90 | 96 | PF00498 | 0.660 |
LIG_LIR_Gen_1 | 29 | 38 | PF02991 | 0.344 |
LIG_LIR_Gen_1 | 65 | 74 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 29 | 33 | PF02991 | 0.344 |
LIG_LIR_Nem_3 | 65 | 71 | PF02991 | 0.520 |
LIG_SH2_CRK | 68 | 72 | PF00017 | 0.548 |
LIG_SH2_PTP2 | 30 | 33 | PF00017 | 0.369 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.369 |
MOD_CK1_1 | 104 | 110 | PF00069 | 0.719 |
MOD_CK1_1 | 111 | 117 | PF00069 | 0.661 |
MOD_CK1_1 | 144 | 150 | PF00069 | 0.658 |
MOD_CK1_1 | 159 | 165 | PF00069 | 0.693 |
MOD_CK1_1 | 55 | 61 | PF00069 | 0.583 |
MOD_CK2_1 | 159 | 165 | PF00069 | 0.654 |
MOD_CK2_1 | 171 | 177 | PF00069 | 0.533 |
MOD_CK2_1 | 90 | 96 | PF00069 | 0.702 |
MOD_GlcNHglycan | 1 | 4 | PF01048 | 0.550 |
MOD_GlcNHglycan | 110 | 113 | PF01048 | 0.712 |
MOD_GlcNHglycan | 117 | 120 | PF01048 | 0.577 |
MOD_GlcNHglycan | 148 | 151 | PF01048 | 0.706 |
MOD_GlcNHglycan | 23 | 27 | PF01048 | 0.487 |
MOD_GSK3_1 | 101 | 108 | PF00069 | 0.682 |
MOD_GSK3_1 | 111 | 118 | PF00069 | 0.637 |
MOD_GSK3_1 | 138 | 145 | PF00069 | 0.650 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.382 |
MOD_GSK3_1 | 52 | 59 | PF00069 | 0.657 |
MOD_NEK2_1 | 56 | 61 | PF00069 | 0.603 |
MOD_PIKK_1 | 66 | 72 | PF00454 | 0.444 |
MOD_PKA_2 | 171 | 177 | PF00069 | 0.579 |
MOD_PKA_2 | 79 | 85 | PF00069 | 0.635 |
MOD_Plk_1 | 168 | 174 | PF00069 | 0.570 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.369 |
MOD_ProDKin_1 | 138 | 144 | PF00069 | 0.715 |
MOD_SUMO_rev_2 | 114 | 123 | PF00179 | 0.762 |
MOD_SUMO_rev_2 | 152 | 162 | PF00179 | 0.766 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 68 | 71 | PF00928 | 0.520 |
TRG_ER_diArg_1 | 192 | 195 | PF00400 | 0.588 |
TRG_NLS_MonoExtC_3 | 159 | 165 | PF00514 | 0.719 |
TRG_NLS_MonoExtC_3 | 75 | 80 | PF00514 | 0.648 |
TRG_NLS_MonoExtN_4 | 73 | 80 | PF00514 | 0.617 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1I6K7 | Leptomonas seymouri | 52% | 99% |
A0A0S4J7Y3 | Bodo saltans | 36% | 100% |
A0A3S5H710 | Leishmania donovani | 100% | 100% |
A4H945 | Leishmania braziliensis | 74% | 100% |
C9ZP33 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 43% | 100% |
E9AR54 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 90% | 100% |
Q4QEA9 | Leishmania major | 95% | 100% |
V5AQX6 | Trypanosoma cruzi | 42% | 78% |